The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion.

@article{LehmannClarke2015TheEO,
  title={The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion.},
  author={Lydia Lehmann-Clarke and Ali Dirani and Irmela Mantel and Aude Ambresin},
  journal={Klinische Monatsblatter fur Augenheilkunde},
  year={2015},
  volume={232 4},
  pages={552-5}
}
BACKGROUND Macular edema resulting from central retinal vein occlusion is effectively treated with anti-vascular endothelial growth factor injections. However, some patients need monthly retreatment and still show frequent recurrences. The purpose of this study was to evaluate the visual and anatomic outcomes of refractory macular edema resulting from ischemic central retinal vein occlusion in patients switched from ranibizumab to aflibercept intravitreal injections. PATIENTS AND METHODS We… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

The Effect of.

  • L n-Clarke
  • Klin Monatsbl Augenheilkd
  • 2015

Similar Papers

Loading similar papers…